Literature DB >> 34978928

A Novel Pneumococcal Surface Protein K of Nonencapsulated Streptococcus pneumoniae Promotes Transmission among Littermates in an Infant Mouse Model with Influenza A Virus Coinfection.

Hideki Sakatani1, Masamitsu Kono1, Denisa Nanushaj1, Daichi Murakami1, Saori Takeda1, Fumie Kaneko1, Moon H Nahm2, Muneki Hotomi1.   

Abstract

We established an infant mouse model for colonization and transmission by nonencapsulated Streptococcus pneumoniae (NESp) strains to gain important information about its virulence among children. Invasive pneumococcal diseases have decreased dramatically since the worldwide introduction of pneumococcal capsular polysaccharide vaccines. Increasing prevalence of nonvaccine serotypes, including NESp, has been highlighted as a challenge in treatment strategy, but the virulence of NESp is not well understood. Protective strategies against NESp colonization and transmission between children require particularly urgent evaluation. NESp lacks capsules, a major virulence factor of pneumococci, but can cause a variety of infections in children and older people. PspK, a specific surface protein of NESp, is a key factor in establishing nasal colonization. In our infant mouse model for colonization and transmission by NESp strains, NESp could establish stable nasal colonization at the same level as encapsulated serotype 6A in infant mice and could be transmitted between littermates. Transmission was promoted by NESp surface virulence factor PspK and influenza virus coinfection. However, PspK deletion mutants lost the ability to colonize and transmit to new hosts. Promotion of NESp transmission by influenza was due to increased susceptibility of the new hosts. PspK was a key factor not only in establishment of nasal colonization but also in transmission to new hosts. PspK may be targeted as a new candidate vaccine for NESp infection in children.

Entities:  

Keywords:  PspK; influenza virus; littermates; nonencapsulated Streptococcus pneumoniae; transmission

Mesh:

Substances:

Year:  2022        PMID: 34978928      PMCID: PMC8853673          DOI: 10.1128/iai.00622-21

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.609


  43 in total

1.  pspK acquisition contributes to the loss of capsule in pneumococci: molecular characterisation of non-encapsulated pneumococci.

Authors:  Takeaki Wajima; Haruna Ishikawa; Akane Iris Matsuzawa; Kanae Yamashita; Shiori Suzuki; Ryuji Osato; Hidemasa Nakaminami; Norihisa Noguchi
Journal:  Microbes Infect       Date:  2020-05-26       Impact factor: 2.700

2.  Association of intrastrain phase variation in quantity of capsular polysaccharide and teichoic acid with the virulence of Streptococcus pneumoniae.

Authors:  J O Kim; J N Weiser
Journal:  J Infect Dis       Date:  1998-02       Impact factor: 5.226

Review 3.  Streptococcus pneumoniae: transmission, colonization and invasion.

Authors:  Jeffrey N Weiser; Daniela M Ferreira; James C Paton
Journal:  Nat Rev Microbiol       Date:  2018-06       Impact factor: 60.633

4.  Bacterial exploitation of phosphorylcholine mimicry suppresses inflammation to promote airway infection.

Authors:  Christopher B Hergott; Aoife M Roche; Nikhil A Naidu; Clementina Mesaros; Ian A Blair; Jeffrey N Weiser
Journal:  J Clin Invest       Date:  2015-08-31       Impact factor: 14.808

5.  Decline in invasive pneumococcal disease after the introduction of protein-polysaccharide conjugate vaccine.

Authors:  Cynthia G Whitney; Monica M Farley; James Hadler; Lee H Harrison; Nancy M Bennett; Ruth Lynfield; Arthur Reingold; Paul R Cieslak; Tamara Pilishvili; Delois Jackson; Richard R Facklam; James H Jorgensen; Anne Schuchat
Journal:  N Engl J Med       Date:  2003-05-01       Impact factor: 91.245

6.  Incidence of pneumococcal disease due to non-pneumococcal conjugate vaccine (PCV7) serotypes in the United States during the era of widespread PCV7 vaccination, 1998-2004.

Authors:  Lauri A Hicks; Lee H Harrison; Brendan Flannery; James L Hadler; William Schaffner; Allen S Craig; Delois Jackson; Ann Thomas; Bernard Beall; Ruth Lynfield; Arthur Reingold; Monica M Farley; Cynthia G Whitney
Journal:  J Infect Dis       Date:  2007-10-04       Impact factor: 5.226

7.  Influenza promotes pneumococcal growth during coinfection by providing host sialylated substrates as a nutrient source.

Authors:  Steven J Siegel; Aoife M Roche; Jeffrey N Weiser
Journal:  Cell Host Microbe       Date:  2014-07-09       Impact factor: 21.023

8.  Isolation, purification and labeling of mouse bone marrow neutrophils for functional studies and adoptive transfer experiments.

Authors:  Muthulekha Swamydas; Michail S Lionakis
Journal:  J Vis Exp       Date:  2013-07-10       Impact factor: 1.355

9.  Epidemiology of invasive pneumococcal disease in older people in Spain (2007-2009): implications for future vaccination strategies.

Authors:  Carmen Ardanuy; José María Marimón; Laura Calatayud; Montserrat Giménez; Marta Alonso; Immaculada Grau; Román Pallarés; Emilio Pérez-Trallero; Josefina Liñares
Journal:  PLoS One       Date:  2012-08-22       Impact factor: 3.240

Review 10.  Recommendations for pneumococcal immunization outside routine childhood immunization programs in Western Europe.

Authors:  Paolo Castiglia
Journal:  Adv Ther       Date:  2014-10-10       Impact factor: 3.845

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.